期刊文献+

母亲MTHFR基因A1298C突变与后代NTDs的关系 被引量:1

Case-control study of relationship between mother MTHFR A1298C mutation and their offspring NTDs
下载PDF
导出
摘要 目的:探讨母亲亚甲基四氢叶酸还原酶(MTHFR)基因A1298C突变与其后代发生NTD s风险性的关系。方法:在山西省搜集41例生育神经管畸形儿的母亲和41例生育正常儿的母亲形成1∶1匹配的病例对照研究,采用PCR-RFLP技术检测研究对象MTHFR基因1298位点多态性。结果:MTHFR基因1298位点呈多态性,本次研究发现两种基因型别A/A、A/C在病例组中为70.7%、29.3%,在对照组中为75.6%、24.4%,经统计学分析,χ2=0.25,P>0.10。等位基因(A、C)频率在病例组(85.4%、14.6%)和对照组(87.8%、12.2%)的分布经分析,χ2=0.21,P>0.10。结论:母亲MTHFR基因A1298C突变与后代NTD s可能无相关性。 Objective: A case - control study was conducted in order to explore the relationship between mother MTHFR A1298C mutation and the risk of fetal neural tube defects (NTDs) . Methods: The case - control study included 41 cases and 41 controls matched in certain conditions. MTHFR genotype at the A1298C site was analyzed by PCR -RFLP method. Results: MTHFR gene in 1298 site had polymorphism. The genotype AA and AC frequencies was 70. 7% and 29. 3% respectively, among cases and 75. 6% and 24. 4% respectively among controls, the differences were statistical significant (χ^2 = 0. 25, P 〉 0. 10), the alley ( A, C) frequencies distribution in cases of 85.4% and 14. 6% and in controls of 87. 8 and 12. 2% were statistical significant (χ^2 = 0. 21, P 〉 0.0 ) too. Conclusion: MTHFR A1298C mutation perhaps has no association with offspring NTDs.
机构地区 山西医科大学
出处 《中国妇幼保健》 CAS 北大核心 2007年第20期2799-2801,共3页 Maternal and Child Health Care of China
基金 山西省教育厅基金资助
关键词 神经管畸形 亚甲基四氢叶酸还原酶基因 PCR-RFLP 多态性 Neural tube defects (NTDs) MTHFR PCR- RFLP Polymorphism
  • 相关文献

参考文献8

  • 1全国妇幼卫生监测办公室.全国妇幼卫生监测年会会议资料.成都:华西医科大学.2000,11.6
  • 2Smithells RB.Possible prevention of neund tube defects by periconeeptional vltmine supplementation.The Lancet,1980:339
  • 3Laurence KM.Increased risk of recurrence of pregnancies complicated by fetal meural tube defects in mothers receiving poor diets,and possible benefit if dietary conselling Br Med J,1990,218:1592
  • 4Steegers-Theunissen RPM,BoersGHJ,Trijbels FJM et al.Maternal hyper-homocyateinemia;a risk factor for neural-tube efects? Metabolism,1994,43(6):1475~1480
  • 5Van der put NMJ,Gabreds F,Stevens EMB et al.A second common mutation in the methylenetetrahydrofolate reducluctase gene:an additional risk factor for neural tube defects.Am J Hum Gene,1998,62:1044
  • 6Hibbanl ED,Smitheiis RW.Folic acid metabolism and human embryoparhy.Lancet,1995.345(12):149
  • 7Ou Cy,Stevenson RE,Brown VK et al.5,10-methylenetetrahydro folate reductase genetic polymirphism as a risk factor for neural tube defeets Am J Med Genet,1996,63(4):610
  • 8Phillip A lsotalo,George A,Wells et al.Neonatal and Fetal Methyle-netetrahydmfolate Reduetase Genetic Polymorphisms:An Examination of C677T And A1298C Mutation.Am.J.Hum.Genet,2000,67:986

同被引文献40

  • 1姜志娥,陈雨历,李金良,郭辰虹.MTHFR基因A1298C多态性与神经管畸形的关系[J].山东大学学报(医学版),2003,41(6):642-645. 被引量:2
  • 2Berry. RJ, Li Z, Eriekson JD, et al. Prevention of neural - tube defects with folic acid in China. China - U. S. Collaborative Project for Neural Tube Defect Prevention. N Engl J Med, 1999, 341 (20) : 1485 1490.
  • 3Moore I,L, Bradlee ML, Singer MR, et al, Folate intake and the risk of neural tube defects: an estimation of dose - response. Epidemiology, 2003, 14(2) : 200 -205.
  • 4Eskes TK. Open or closed? A world of difference: a history of homo- cysteine research. Nutr Rev, 1998, 56(8) : 236 -244.
  • 5Nishio K, Goto Y, Kondo T, et al. Serum folate and methylenetetrahydrofolate reduetase (MTHFR) C677T polymorphism adjusted for folate intake. J Epidemiol, 2008, 18(3) : 125 -131.
  • 6Jacques PF, Bostom AG, Williams RR, et al. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation, 1996, 93 ( 1 ) : 7 - 9.
  • 7De Bree A, Versehuren WM, Bjorke - Monsen AL, et al. Effect of the methylenetetrahydrofolate reductase 677C→T mutation on the relations among folate intake and plasma folate and homocysteine concentrations in a general population sample. Am J Clin Nutr, 2003, 77 (3) : 687 - 693.
  • 8Van der Put NM, Steegers - Theunissen RP, Frosst P, et al. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet, 1995, 3d-6 ( 8982 ) : 1070 - 1071.
  • 9Volcik KA, Blanton SH, Tyerman GH, et al. Methylenetetrahydrofo- late reductase and spina bifida: evaluation of level of defect and maternal genotypic risk in Hispanics. Am J Med Genet, 2000, 95 ( 1 ) : 21 -27.
  • 10郑梅玲 王刚华 张桂林.血浆同型半胱氨酸(HCY)及其代谢酶基因多态性与神经管畸形的关系[J].中国优生优育,2007,13(4):158-161.

引证文献1

二级引证文献132

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部